English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Personalised medicine is treatment tailored to the individual's needs. This approach is being encouraged by NHS England to improve patient care. The advent of biosimilar drugs in rheumatology has led to therapy re-appraisals driven by the clinical commissioning group's demand for cost-effective

clinical medicine

Personalising care: using infliximab drug trough and anti-drug antibody levels improves clinical treatment decisions and is a cost-effective strategy in spondyloarthritis